Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Aspirin and N-acetylcysteine co-administration markedly inhibit chronic ethanol intake and block relapse binge drinking: Role of neuroinflammation-oxidative stress self-perpetuation.

Israel Y, Quintanilla ME, Ezquer F, Morales P, Santapau D, Berríos-Cárcamo P, Ezquer M, Olivares B, Herrera-Marschitz M.

Addict Biol. 2019 Nov 15:e12853. doi: 10.1111/adb.12853. [Epub ahead of print]

PMID:
31733014
2.

Intranasal mesenchymal stem cell secretome administration markedly inhibits alcohol and nicotine self-administration and blocks relapse-intake: mechanism and translational options.

Quintanilla ME, Ezquer F, Morales P, Santapau D, Berríos-Cárcamo P, Ezquer M, Herrera-Marschitz M, Israel Y.

Stem Cell Res Ther. 2019 Jul 8;10(1):205. doi: 10.1186/s13287-019-1304-z.

3.

Gene and cell therapy on the acquisition and relapse-like binge drinking in a model of alcoholism: translational options.

Yedy Israel, Quintanilla ME, Ezquer F, Morales P, Rivera-Meza M, Karahanian E, Ezquer M, Herrera-Marschitz M.

Gene Ther. 2019 Feb 28. doi: 10.1038/s41434-019-0064-9. [Epub ahead of print] Review.

PMID:
30820030
4.

Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma.

Rosenberger L, Ezquer M, Lillo-Vera F, Pedraza PL, Ortúzar MI, González PL, Figueroa-Valdés AI, Cuenca J, Ezquer F, Khoury M, Alcayaga-Miranda F.

Sci Rep. 2019 Jan 24;9(1):663. doi: 10.1038/s41598-018-36855-6.

5.

Intranasal delivery of mesenchymal stem cell-derived exosomes reduces oxidative stress and markedly inhibits ethanol consumption and post-deprivation relapse drinking.

Ezquer F, Quintanilla ME, Morales P, Santapau D, Ezquer M, Kogan MJ, Salas-Huenuleo E, Herrera-Marschitz M, Israel Y.

Addict Biol. 2019 Sep;24(5):994-1007. doi: 10.1111/adb.12675. Epub 2018 Sep 21.

PMID:
30239077
6.

Characterization of diabetic neuropathy progression in a mouse model of type 2 diabetes mellitus.

De Gregorio C, Contador D, Campero M, Ezquer M, Ezquer F.

Biol Open. 2018 Sep 5;7(9). pii: bio036830. doi: 10.1242/bio.036830.

7.

Commonality of Ethanol and Nicotine Reinforcement and Relapse in Wistar-Derived UChB Rats: Inhibition by N-Acetylcysteine.

Quintanilla ME, Morales P, Ezquer F, Ezquer M, Herrera-Marschitz M, Israel Y.

Alcohol Clin Exp Res. 2018 Oct;42(10):1988-1999. doi: 10.1111/acer.13842. Epub 2018 Aug 13.

PMID:
30035805
8.

The Reparative Abilities of Menstrual Stem Cells Modulate the Wound Matrix Signals and Improve Cutaneous Regeneration.

Cuenca J, Le-Gatt A, Castillo V, Belletti J, Díaz M, Kurte G M, Gonzalez PL, Alcayaga-Miranda F, Schuh CMAP, Ezquer F, Ezquer M, Khoury M.

Front Physiol. 2018 May 14;9:464. doi: 10.3389/fphys.2018.00464. eCollection 2018.

9.

Intravenous administration of anti-inflammatory mesenchymal stem cell spheroids reduces chronic alcohol intake and abolishes binge-drinking.

Ezquer F, Morales P, Quintanilla ME, Santapau D, Lespay-Rebolledo C, Ezquer M, Herrera-Marschitz M, Israel Y.

Sci Rep. 2018 Mar 22;8(1):4325. doi: 10.1038/s41598-018-22750-7.

10.

Activated mesenchymal stem cell administration inhibits chronic alcohol drinking and suppresses relapse-like drinking in high-alcohol drinker rats.

Ezquer F, Quintanilla ME, Morales P, Ezquer M, Lespay-Rebolledo C, Herrera-Marschitz M, Israel Y.

Addict Biol. 2019 Jan;24(1):17-27. doi: 10.1111/adb.12572. Epub 2017 Oct 18.

PMID:
29044813
11.

Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy.

Oses C, Olivares B, Ezquer M, Acosta C, Bosch P, Donoso M, Léniz P, Ezquer F.

PLoS One. 2017 May 19;12(5):e0178011. doi: 10.1371/journal.pone.0178011. eCollection 2017.

12.

Acquisition, Maintenance and Relapse-Like Alcohol Drinking: Lessons from the UChB Rat Line.

Israel Y, Karahanian E, Ezquer F, Morales P, Ezquer M, Rivera-Meza M, Herrera-Marschitz M, Quintanilla ME.

Front Behav Neurosci. 2017 Apr 4;11:57. doi: 10.3389/fnbeh.2017.00057. eCollection 2017. Review.

13.
14.

Intracerebral Stem Cell Administration Inhibits Relapse-like Alcohol Drinking in Rats.

Israel Y, Ezquer F, Quintanilla ME, Morales P, Ezquer M, Herrera-Marschitz M.

Alcohol Alcohol. 2017 Jan;52(1):1-4. doi: 10.1093/alcalc/agw068. Epub 2016 Sep 20.

PMID:
27651282
15.

High Fat Diet-Induced Skeletal Muscle Wasting Is Decreased by Mesenchymal Stem Cells Administration: Implications on Oxidative Stress, Ubiquitin Proteasome Pathway Activation, and Myonuclear Apoptosis.

Abrigo J, Rivera JC, Aravena J, Cabrera D, Simon F, Ezquer F, Ezquer M, Cabello-Verrugio C.

Oxid Med Cell Longev. 2016;2016:9047821. doi: 10.1155/2016/9047821. Epub 2016 Aug 8.

16.

Two complementary strategies to improve cell engraftment in mesenchymal stem cell-based therapy: Increasing transplanted cell resistance and increasing tissue receptivity.

Ezquer FE, Ezquer ME, Vicencio JM, Calligaris SD.

Cell Adh Migr. 2017 Jan 2;11(1):110-119. doi: 10.1080/19336918.2016.1197480. Epub 2016 Jun 13. Review.

17.

Changes of myoid and endothelial cells in the peritubular wall during contraction of the seminiferous tubule.

Losinno AD, Sorrivas V, Ezquer M, Ezquer F, López LA, Morales A.

Cell Tissue Res. 2016 Aug;365(2):425-35. doi: 10.1007/s00441-016-2386-x. Epub 2016 Mar 18.

PMID:
26987820
18.

Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice.

Ezquer M, Urzua CA, Montecino S, Leal K, Conget P, Ezquer F.

Stem Cell Res Ther. 2016 Mar 16;7:42. doi: 10.1186/s13287-016-0299-y.

19.

Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease.

Ezquer F, Bruna F, Calligaris S, Conget P, Ezquer M.

World J Gastroenterol. 2016 Jan 7;22(1):24-36. doi: 10.3748/wjg.v22.i1.24. Review.

20.

Nerve excitability and structural changes in myelinated axons from diabetic mice.

Campero M, Ezquer M, Ezquer F.

Exp Clin Endocrinol Diabetes. 2015 Sep;123(8):485-91. doi: 10.1055/s-0035-1559606. Epub 2015 Aug 18.

PMID:
26285066
21.

Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus.

Ezquer F, Giraud-Billoud M, Carpio D, Cabezas F, Conget P, Ezquer M.

Biomed Res Int. 2015;2015:164703. doi: 10.1155/2015/164703. Epub 2015 Jun 8.

22.

Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears.

Ezquer F, Gutiérrez J, Ezquer M, Caglevic C, Salgado HC, Calligaris SD.

Stem Cell Res Ther. 2015 Jun 24;6:116. doi: 10.1186/s13287-015-0109-y. Review.

23.

Carbon monoxide: A new player in the redox regulation of connexin hemichannels.

Retamal MA, León-Paravic CG, Ezquer M, Ezquer F, Del Rio R, Pupo A, Martínez AD, González C.

IUBMB Life. 2015 Jun;67(6):428-37. doi: 10.1002/iub.1388. Epub 2015 May 29. Review.

24.

Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?

Arango-Rodriguez ML, Ezquer F, Ezquer M, Conget P.

World J Stem Cells. 2015 Mar 26;7(2):408-17. doi: 10.4252/wjsc.v7.i2.408. Review.

25.

Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells.

Contador D, Ezquer F, Espinosa M, Arango-Rodriguez M, Puebla C, Sobrevia L, Conget P.

Exp Biol Med (Maywood). 2015 Sep;240(9):1235-46. doi: 10.1177/1535370214566565. Epub 2015 Jan 16.

26.

Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?

Ezquer F, Ezquer M, Arango-Rodriguez M, Conget P.

Acta Ophthalmol. 2014 Mar;92(2):e86-95. doi: 10.1111/aos.12113. Epub 2013 Jun 15. Review.

27.

MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy.

Ezquer ME, Ezquer FE, Arango-Rodríguez ML, Conget PA.

Biol Res. 2012;45(3):289-96. doi: 10.4067/S0716-97602012000300010. Review.

28.
29.

Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.

Ezquer M, Ezquer F, Ricca M, Allers C, Conget P.

J Hepatol. 2011 Nov;55(5):1112-20. doi: 10.1016/j.jhep.2011.02.020. Epub 2011 Feb 26.

PMID:
21356258
30.

The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells.

Ezquer F, Ezquer M, Simon V, Conget P.

PLoS One. 2011 Jan 27;6(1):e16566. doi: 10.1371/journal.pone.0016566.

31.

Insulin is secreted upon glucose stimulation by both gastrointestinal enteroendocrine K-cells and L-cells engineered with the preproinsulin gene.

Encina G, Ezquer F, Conget P, Israel Y.

Biol Res. 2011;44(3):301-5. doi: /S0716-97602011000300012. Epub 2011 Nov 7.

32.

Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.

Ezquer F, Ezquer M, Simon V, Pardo F, Yañez A, Carpio D, Conget P.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1354-65. doi: 10.1016/j.bbmt.2009.07.022.

33.

Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.

Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA.

Biol Blood Marrow Transplant. 2008 Jun;14(6):631-40. doi: 10.1016/j.bbmt.2008.01.006. Epub 2008 Apr 14.

34.

Hereditary hemochromatosis: an opportunity for gene therapy.

Ezquer F, Núñez MT, Rojas A, Asenjo J, Israel Y.

Biol Res. 2006;39(1):113-24.

35.

Antisense gene delivered by an adenoassociated viral vector inhibits iron uptake in human intestinal cells: potential application in hemochromatosis.

Ezquer F, Núñez MT, Israel Y.

Biochem Pharmacol. 2005 Jun 1;69(11):1559-66. Epub 2005 Apr 22.

PMID:
15896335
36.

Supplemental Content

Loading ...
Support Center